InduPro
Proximity by design
Proximity by design
InduPro is a biotechnology startup founded in 2022 with the slogan "Proximity by design". The company is focused on bringing life-changing therapies to patients by leveraging novel cell-surface platform technologies. InduPro aims to redefine and manipulate protein interactions beyond natural signaling paradigms, integrating inherent protein proximity at the cell surface with the ability to manipulate protein pairings via induced protein proximity to create novel signaling pathways and logic gates.
As a United States-based company, InduPro is positioned at the forefront of biotechnological innovation, seeking to revolutionize the landscape of medical treatments through its pioneering approach.
Currently, there is no publicly available information on InduPro's last investment or the investors involved. However, the company's unique focus on manipulating protein interactions and creating novel signaling pathways holds significant promise for the biotechnology industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $85.00M | 5 |
|
13 Jun 2024 |
No recent news or press coverage available for InduPro.
We care about your data, and we'd love to use cookies make your experience better.
